APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-driven Peptide Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI-driven Peptide Drug Discovery Platform Market Outlook and Growth Opportunities 2026

5 June 2026202 pages

Choose your research edition.

Industry ResearchAI-driven Peptide Drug Discovery Platform Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-driven Peptide Drug Discovery Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI-driven Peptide Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-driven Peptide Drug Discovery Platform Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-driven Peptide Drug Discovery Platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global AI-driven Peptide Drug Discovery Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI-driven Peptide Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI-driven Peptide Drug Discovery Platform market include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI and Insilico Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI-driven Peptide Drug Discovery Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-driven Peptide Drug Discovery Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-driven Peptide Drug Discovery Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-driven Peptide Drug Discovery Platform market.

AI-driven Peptide Drug Discovery Platform Segment by Company

Peptilogics

Pepticom Ltd

Menten AI

GUBRA

Creative Peptides

Exscalate

Generate Biomedicines

Receptor.AI

Insilico Medicine

Schrödinger

BenevolentAI

Evotec

PeptiFinder

Xtalpi

Sun Novo

Zonsen Peplib Biotech

Tide Tron Biotech

AI-driven Peptide Drug Discovery Platform Segment by Type

Design and Generation Platform

Screening and Optimization Platform

Data-driven Platform

Others

AI-driven Peptide Drug Discovery Platform Segment by Application

Scientific Research

Pharmaceuticals

AI-driven Peptide Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI-driven Peptide Drug Discovery Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI-driven Peptide Drug Discovery Platform key companies, revenue, market share, and recent developments.

3. To split the AI-driven Peptide Drug Discovery Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI-driven Peptide Drug Discovery Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI-driven Peptide Drug Discovery Platform significant trends, drivers, influence factors in global and regions.

6. To analyze AI-driven Peptide Drug Discovery Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-driven Peptide Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-driven Peptide Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-driven Peptide Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-driven Peptide Drug Discovery Platform industry.

Chapter 3: Detailed analysis of AI-driven Peptide Drug Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI-driven Peptide Drug Discovery Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI-driven Peptide Drug Discovery Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI-driven Peptide Drug Discovery Platform Industry Trends Table 2. AI-driven Peptide Drug Discovery Platform Industry Drivers Table 3. AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges Table 4. AI-driven Peptide Drug Discovery Platform Industry Restraints Table 5. Global AI-driven Peptide Drug Discovery Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI-driven Peptide Drug Discovery Platform Revenue Share by Company (2021-2026) Table 7. Global AI-driven Peptide Drug Discovery Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI-driven Peptide Drug Discovery Platform Key Company Manufacturing Base & Headquarters Table 9. Global AI-driven Peptide Drug Discovery Platform Company, Product Type & Application Table 10. Global AI-driven Peptide Drug Discovery Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI-driven Peptide Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Design and Generation Platform Table 15. Significant Companies of Screening and Optimization Platform Table 16. Significant Companies of Data-driven Platform Table 17. Significant Companies of Others Table 18. Global AI-driven Peptide Drug Discovery Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI-driven Peptide Drug Discovery Platform Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI-driven Peptide Drug Discovery Platform Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Type (2021-2026) Table 22. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Scientific Research Table 24. Significant Companies of Pharmaceuticals Table 25. Global AI-driven Peptide Drug Discovery Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI-driven Peptide Drug Discovery Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI-driven Peptide Drug Discovery Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Application (2021-2026) Table 29. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Application (2027-2032) Table 30. Global AI-driven Peptide Drug Discovery Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI-driven Peptide Drug Discovery Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Region (2021-2026) Table 33. Global AI-driven Peptide Drug Discovery Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Region (2027-2032) Table 35. Global AI-driven Peptide Drug Discovery Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI-driven Peptide Drug Discovery Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI-driven Peptide Drug Discovery Platform Sales Value Market Share by Country (2021-2026) Table 38. Global AI-driven Peptide Drug Discovery Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI-driven Peptide Drug Discovery Platform Sales Value Market Share by Country (2027-2032) Table 40. Peptilogics Company Information Table 41. Peptilogics Business Overview Table 42. Peptilogics AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio Table 44. Peptilogics Recent Development Table 45. Pepticom Ltd Company Information Table 46. Pepticom Ltd Business Overview Table 47. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio Table 49. Pepticom Ltd Recent Development Table 50. Menten AI Company Information Table 51. Menten AI Business Overview Table 52. Menten AI AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 54. Menten AI Recent Development Table 55. GUBRA Company Information Table 56. GUBRA Business Overview Table 57. GUBRA AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio Table 59. GUBRA Recent Development Table 60. Creative Peptides Company Information Table 61. Creative Peptides Business Overview Table 62. Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio Table 64. Creative Peptides Recent Development Table 65. Exscalate Company Information Table 66. Exscalate Business Overview Table 67. Exscalate AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio Table 69. Exscalate Recent Development Table 70. Generate Biomedicines Company Information Table 71. Generate Biomedicines Business Overview Table 72. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio Table 74. Generate Biomedicines Recent Development Table 75. Receptor.AI Company Information Table 76. Receptor.AI Business Overview Table 77. Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 79. Receptor.AI Recent Development Table 80. Insilico Medicine Company Information Table 81. Insilico Medicine Business Overview Table 82. Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio Table 84. Insilico Medicine Recent Development Table 85. Schrödinger Company Information Table 86. Schrödinger Business Overview Table 87. Schrödinger AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio Table 89. Schrödinger Recent Development Table 90. BenevolentAI Company Information Table 91. BenevolentAI Business Overview Table 92. BenevolentAI AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 94. BenevolentAI Recent Development Table 95. Evotec Company Information Table 96. Evotec Business Overview Table 97. Evotec AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio Table 99. Evotec Recent Development Table 100. PeptiFinder Company Information Table 101. PeptiFinder Business Overview Table 102. PeptiFinder AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio Table 104. PeptiFinder Recent Development Table 105. Xtalpi Company Information Table 106. Xtalpi Business Overview Table 107. Xtalpi AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio Table 109. Xtalpi Recent Development Table 110. Sun Novo Company Information Table 111. Sun Novo Business Overview Table 112. Sun Novo AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio Table 114. Sun Novo Recent Development Table 115. Zonsen Peplib Biotech Company Information Table 116. Zonsen Peplib Biotech Business Overview Table 117. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 119. Zonsen Peplib Biotech Recent Development Table 120. Tide Tron Biotech Company Information Table 121. Tide Tron Biotech Business Overview Table 122. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 124. Tide Tron Biotech Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. AI-driven Peptide Drug Discovery Platform Product Image Figure 2. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global AI-driven Peptide Drug Discovery Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Design and Generation Platform Image Figure 8. Screening and Optimization Platform Image Figure 9. Data-driven Platform Image Figure 10. Others Image Figure 11. Global AI-driven Peptide Drug Discovery Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI-driven Peptide Drug Discovery Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Type (2021-2032) Figure 14. Scientific Research Image Figure 15. Pharmaceuticals Image Figure 16. Global AI-driven Peptide Drug Discovery Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI-driven Peptide Drug Discovery Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Application (2021-2032) Figure 19. Global AI-driven Peptide Drug Discovery Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI-driven Peptide Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI-driven Peptide Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI-driven Peptide Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI-driven Peptide Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI-driven Peptide Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Design and Generation Platform
  • Screening and Optimization Platform
  • Data-driven Platform
  • Others
Applications
  • Scientific Research
  • Pharmaceuticals
Companies covered
  • Peptilogics
  • Pepticom Ltd
  • Menten AI
  • GUBRA
  • Creative Peptides
  • Exscalate
  • Generate Biomedicines
  • Receptor.AI
  • Insilico Medicine
  • Schrödinger
  • BenevolentAI
  • Evotec
  • PeptiFinder
  • Xtalpi
  • Sun Novo
  • Zonsen Peplib Biotech
  • Tide Tron Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI-driven Peptide Drug Discovery Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI-driven Peptide Drug Discovery Platform Market Dynamics
  1. 2.1 AI-driven Peptide Drug Discovery Platform Industry Trends
  2. 2.2 AI-driven Peptide Drug Discovery Platform Industry Drivers
  3. 2.3 AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 AI-driven Peptide Drug Discovery Platform Industry Restraints
3 AI-driven Peptide Drug Discovery Platform Market by Company
  1. 3.1 Global AI-driven Peptide Drug Discovery Platform Company Revenue Ranking in 2025
  2. 3.2 Global AI-driven Peptide Drug Discovery Platform Revenue by Company (2021-2026)
  3. 3.3 Global AI-driven Peptide Drug Discovery Platform Company Ranking (2024-2026)
  4. 3.4 Global AI-driven Peptide Drug Discovery Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global AI-driven Peptide Drug Discovery Platform Company Product Type and Application
  6. 3.6 Global AI-driven Peptide Drug Discovery Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI-driven Peptide Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI-driven Peptide Drug Discovery Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI-driven Peptide Drug Discovery Platform Market by Type
  1. 4.1 AI-driven Peptide Drug Discovery Platform Type Introduction
  2. 4.1.1 Design and Generation Platform
  3. 4.1.2 Screening and Optimization Platform
  4. 4.1.3 Data-driven Platform
  5. 4.1.4 Others
  6. 4.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Type
  7. 4.2.1 Global AI-driven Peptide Drug Discovery Platform Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Type (2021-2032)
5 AI-driven Peptide Drug Discovery Platform Market by Application
  1. 5.1 AI-driven Peptide Drug Discovery Platform Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Pharmaceuticals
  4. 5.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Application
  5. 5.2.1 Global AI-driven Peptide Drug Discovery Platform Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Application (2021-2032)
  7. 5.2.3 Global AI-driven Peptide Drug Discovery Platform Sales Value Share by Application (2021-2032)
6 AI-driven Peptide Drug Discovery Platform Regional Value Analysis
  1. 6.1 Global AI-driven Peptide Drug Discovery Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI-driven Peptide Drug Discovery Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032)
  7. 6.3.2 North America AI-driven Peptide Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032)
  10. 6.4.2 Europe AI-driven Peptide Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032)
  16. 6.6.2 South America AI-driven Peptide Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
7 AI-driven Peptide Drug Discovery Platform Country-level Value Analysis
  1. 7.1 Global AI-driven Peptide Drug Discovery Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI-driven Peptide Drug Discovery Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI-driven Peptide Drug Discovery Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI-driven Peptide Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI-driven Peptide Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI-driven Peptide Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Peptilogics
  2. 8.1.1 Peptilogics Company Information
  3. 8.1.2 Peptilogics Business Overview
  4. 8.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio
  6. 8.1.5 Peptilogics Recent Developments
  7. 8.2 Pepticom Ltd
  8. 8.2.1 Pepticom Ltd Company Information
  9. 8.2.2 Pepticom Ltd Business Overview
  10. 8.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio
  12. 8.2.5 Pepticom Ltd Recent Developments
  13. 8.3 Menten AI
  14. 8.3.1 Menten AI Company Information
  15. 8.3.2 Menten AI Business Overview
  16. 8.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  18. 8.3.5 Menten AI Recent Developments
  19. 8.4 GUBRA
  20. 8.4.1 GUBRA Company Information
  21. 8.4.2 GUBRA Business Overview
  22. 8.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio
  24. 8.4.5 GUBRA Recent Developments
  25. 8.5 Creative Peptides
  26. 8.5.1 Creative Peptides Company Information
  27. 8.5.2 Creative Peptides Business Overview
  28. 8.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio
  30. 8.5.5 Creative Peptides Recent Developments
  31. 8.6 Exscalate
  32. 8.6.1 Exscalate Company Information
  33. 8.6.2 Exscalate Business Overview
  34. 8.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio
  36. 8.6.5 Exscalate Recent Developments
  37. 8.7 Generate Biomedicines
  38. 8.7.1 Generate Biomedicines Company Information
  39. 8.7.2 Generate Biomedicines Business Overview
  40. 8.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio
  42. 8.7.5 Generate Biomedicines Recent Developments
  43. 8.8 Receptor.AI
  44. 8.8.1 Receptor.AI Company Information
  45. 8.8.2 Receptor.AI Business Overview
  46. 8.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  48. 8.8.5 Receptor.AI Recent Developments
  49. 8.9 Insilico Medicine
  50. 8.9.1 Insilico Medicine Company Information
  51. 8.9.2 Insilico Medicine Business Overview
  52. 8.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio
  54. 8.9.5 Insilico Medicine Recent Developments
  55. 8.10 Schrödinger
  56. 8.10.1 Schrödinger Company Information
  57. 8.10.2 Schrödinger Business Overview
  58. 8.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio
  60. 8.10.5 Schrödinger Recent Developments
  61. 8.11 BenevolentAI
  62. 8.11.1 BenevolentAI Company Information
  63. 8.11.2 BenevolentAI Business Overview
  64. 8.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio
  66. 8.11.5 BenevolentAI Recent Developments
  67. 8.12 Evotec
  68. 8.12.1 Evotec Company Information
  69. 8.12.2 Evotec Business Overview
  70. 8.12.3 Evotec AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio
  72. 8.12.5 Evotec Recent Developments
  73. 8.13 PeptiFinder
  74. 8.13.1 PeptiFinder Company Information
  75. 8.13.2 PeptiFinder Business Overview
  76. 8.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio
  78. 8.13.5 PeptiFinder Recent Developments
  79. 8.14 Xtalpi
  80. 8.14.1 Xtalpi Company Information
  81. 8.14.2 Xtalpi Business Overview
  82. 8.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio
  84. 8.14.5 Xtalpi Recent Developments
  85. 8.15 Sun Novo
  86. 8.15.1 Sun Novo Company Information
  87. 8.15.2 Sun Novo Business Overview
  88. 8.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio
  90. 8.15.5 Sun Novo Recent Developments
  91. 8.16 Zonsen Peplib Biotech
  92. 8.16.1 Zonsen Peplib Biotech Company Information
  93. 8.16.2 Zonsen Peplib Biotech Business Overview
  94. 8.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  96. 8.16.5 Zonsen Peplib Biotech Recent Developments
  97. 8.17 Tide Tron Biotech
  98. 8.17.1 Tide Tron Biotech Company Information
  99. 8.17.2 Tide Tron Biotech Business Overview
  100. 8.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  102. 8.17.5 Tide Tron Biotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst